Stockscreener 앱 받기
17.28
3.57%
-0.64
시간 외 거래:
17.28
Ceribell Inc 주식(CBLL)의 최신 뉴스
High-Profile Insider Move Shakes Up Investor Buzz at Ceribell, Inc. - TipRanks
Insider Sell Alert: Joseph Taylor Sells 5,500 Shares of CeriBell Inc (CBLL) - GuruFocus
Ceribell director Joseph Taylor sells $101,255 in common stock By Investing.com - Investing.com South Africa
Ceribell director Joseph Taylor sells $101,255 in common stock - Investing.com
Ceribell, Inc. launches FDA-cleared device for bedside diagnosis and delirium monitoring - Traders Union
Ceribell Insider Sold Shares Worth $714,870, According to a Recent SEC Filing - Moomoo
CBLL Q1 2026 Earnings: EPS Misses Estimates as Losses Widen, Shares DeclinePre-Earnings Drift - newsline.com
Ceribell CEO Chao sells $714,870 in common stock By Investing.com - Investing.com Nigeria
Ceribell CEO Chao sells $714,870 in common stock - Investing.com
CeriBell Inc. (CBLL) Shows Strength with 4% Gain: Technical Levels and Market ContextIsland Reversal - newsline.com
FDA-approved ceribell EEG shortens seizure diagnosis by monitoring brain activity - CBS News
Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes - The Manila Times
Ceribell Announces New Critical Care Medicine Publication - GlobeNewswire
CBLL Q1 2026 Earnings: Wider-than-Expected Loss Disappoints InvestorsSlow Growth Warning - newsline.com
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
William Blair Maintains Ceribell(CBLL.US) With Buy Rating - Moomoo
Ceribell Announces Director Elections at 2026 Annual Meeting - The Globe and Mail
CBLL Technical Analysis | Trend, Signals & Chart Patterns | CERIBELL INC (NASDAQ:CBLL) - ChartMill
CeriBell (CBLL) 10K Form and Latest SEC Filings 2026 - MarketBeat
InvestingPro’s Fair Value warned of CeriBell crash 17 months ago By Investing.com - Investing.com
CBLL Q1 2026 Earnings: Wider-than-Expected Loss Raises ConcernsBanking Earnings Report - newsline.com
Ceribell Leadership Unloads Shares in a Wave of Insider Stock Moves - TipRanks
CeriBell (CBLL) Holds Near Support Amid Modest GainsFibonacci Fan - newsline.com
EEG adoption accelerates in urgent seizure detection, Ceribell, Inc. pushes - Traders Union
CeriBell Inc. (CBLL) Q1 2026 Earnings: EPS Misses Estimates by 30.7%, Stock Edges HigherEarnings Seasonality - newsline.com
Ceribell CEO to present at William Blair Growth Stock Conference on June 3, 2026 - Pluang
Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference - Moomoo
Earnings call transcript: Ceribell Inc. Q1 2026 misses EPS, revenue up - Investing.com Nigeria
Bank of America Securities Remains a Buy on Ceribell, Inc. (CBLL) - The Globe and Mail
Canaccord Genuity maintains Ceribell (CBLL) buy recommendation - MSN
Ceribell anticipates $112M-$116M 2026 revenue while targeting delirium NTAP of up to $2,171 per patient - MSN
CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit Records - Yahoo Finance
Ladenburg Thalmann Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $32 - Moomoo
Middle East Tensions Threaten Ceribell’s Supply Chain, Shipping Routes, and Margins - TipRanks
Ceribell’s Earnings Call Signals Growth Over Profits - The Globe and Mail
TD Cowen Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $29 - Moomoo
A Quick Look at Today's Ratings for Ceribell(CBLL.US), With a Forecast Between $25 to $29 - Moomoo
Canaccord lowers Ceribell stock price target on valuation compression By Investing.com - Investing.com Australia
Canaccord lowers Ceribell stock price target on valuation compression - Investing.com
Ceribell: Buy Rating Reiterated on Strong Q1 Momentum and Expanded TAM, $28 Price Target Maintained - TipRanks
Ceribell, Inc. (CBLL) reports Q1 loss, beats revenue estimates - MSN
CeriBell Q1 Earnings Call Highlights - inkl
CeriBell (CBLL) Q1 2026 Earnings Transcript - AOL.com
CeriBell, Inc. (CBLL) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
CeriBell Q1 Loss Widens, Revenue Rises; Lifts Full-Year Revenue Guidance - Moomoo
Ceribell Inc (NASDAQ:CBLL) Q1 Revenue Beats Estimates, Net Loss Widens, Full-Year Guidance Raised - ChartMill
2.43%
자본화:
|
볼륨(24시간):